NAMPAK LIMITED - Trading statement for the year ended 30 September 2026
What this filing means
Nampak's FY26 trading statement shows reported earnings expected to fall hard while the normalised measure barely moves. Continuing-operations HEPS is guided 34% to 38% lower at 6 500 to 6 900 cents, and total-operations EPS is guided down 80% to 81% to 8 100 to 8 500 cents, mainly on the non-recurrence of a R2.4 billion FY25 disposal profit. The normalised HEPS figure of 7 500 to 7 900 cents, up 2% to 8%, is issuer-defined and excludes the once-off items that drove the reported decline. A Zimbabwe stake sale is also announced, subject to suspensive conditions.
Nampak is telling shareholders that the profit number most people look at is expected to be much lower than last year, mostly because last year included a once-off R2.4 billion gain from selling businesses that will not repeat. The company also points to a 'normalised' profit figure that strips out those once-off items and shows a small increase, but that measure is one the company defines itself, so it is not directly comparable to the standard JSE measure. The Zimbabwe stake sale is still subject to conditions, so it is not yet done.
Bull case
- Continuing-operations normalised HEPS is expected to increase by between 2% and 8% to between 7 500.0 cents and 7 900.0 cents.
- The proposed NZL transaction enables Nampak to realise cash while retaining exposure to potential value from forestry property rights and previously impaired treasury bills.
Bear case
- Continuing-operations HEPS is expected to decline by between 34% and 38% to 6 500.0 cents and 6 900.0 cents, despite the stated increase in normalised HEPS.
- Continuing-operations EPS is expected to decline by between 26% and 31% to 9 700.0 cents and 10 300.0 cents.
- Normalised HEPS was adversely affected by a decline in the contribution of Diversified, only partially offset by lower finance costs.
- The filing provides no cash-flow or net-debt data, limiting assessment of the group's cash generation and balance-sheet position.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
The fundamental direction is negative: reported HEPS is guided down 34% to 38% on continuing operations and total EPS down 80% to 81%, driven by the non-recurrence of a R2.4 billion FY25 disposal profit and a R125 million Zimbabwe impairment. The normalised HEPS increase of 2% to 8% is issuer-defined and excludes those items, so it does not offset the reported decline. The proposed NZL disposal is directionally constructive but remains subject to suspensive conditions and is not yet complete. So what: the market still needs the audited results on 2 December to see cash flow, net debt and segment detail, and to confirm whether the Zimbabwe sale closes.
The audited results on 2 December are where the market will test cash flow, net debt and whether the Zimbabwe disposal completes.
Evidence from the filing
Continuing-operations normalised HEPS is expected to increase by between 2% and 8% to between 7 500.0 cents and 7 900.0 cents.
“Normalised headline earnings per share for the group (“Normalised HEPS”), adjusting for the per share post- tax effects of defined capital and other items, is expected to be between 7 500.0 cents and 7 900.0 cents compared to 7 336.5 cents in FY25, an increase of between 2% and 8%.”
The proposed NZL transaction enables Nampak to realise cash while retaining exposure to potential value from forestry property rights and previously impaired treasury bills.
“The proposed transaction allows Nampak to realise cash, whilst retaining the ability to recover further value from the investment if the economy improves and management realises value from historically encumbered forestry property rights. Retaining an interest also supports efforts to secure value from previously impaired treasury bills which remain an asset of the group.”
Continuing-operations HEPS is expected to decline by between 34% and 38% to 6 500.0 cents and 6 900.0 cents, despite the stated increase in normalised HEPS.
“HEPS of between 6 500.0 cents and 6 900.0 cents compared to HEPS of 10 510.0 cents in FY25, a decrease of between 34% and 38%; and”
Continuing-operations EPS is expected to decline by between 26% and 31% to 9 700.0 cents and 10 300.0 cents.
“EPS of between 9 700.0 cents and 10 300.0 cents compared to EPS of 13 971.8 cents in FY25, a decrease of between 26% and 31%.”
Normalised HEPS was adversely affected by a decline in the contribution of Diversified, only partially offset by lower finance costs.
“Normalised HEPS has been impacted by a decline in the contribution of Diversified, partially offset by a R146 million (post-tax) reduction in finance costs.”
More on Nampak Limited
Related filings
More from NPK
- NAMPAK LIMITED - Dealings in securities by an associate of a director
- NAMPAK LIMITED - Dealings in securities by an associate of a director
- NAMPAK LIMITED - Dealings in securities by an associate of a director
- NAMPAK LIMITED - Dealings in securities by an associate of a director
- NAMPAK LIMITED - Dealing in securities by director and an associate of a director